Literature DB >> 25566347

Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe's disease: a case report.

Divyajot Sandhu1, Adam Rizvi1, Jae Kim1, Rwoof Reshi1.   

Abstract

BACKGROUND: Pompe's disease is a glycogen storage disease that manifests as progressive neuropathy, and myopathy. There are a few reports of vasculopathy in this disease, thought to be from small- and medium-vessel arteriopathy. We present a case of late-onset Pompe's disease with microhemorrhages and review of the pertinent literature.
METHODS: We describe a case of microhemorrhages in a patient with known late-onset Pompe's disease.
RESULTS: Our patient was noted to have numerous microhemorrhages concentrated in the posterior circulation distribution in what can best be described as central microhemorrhages, distinct from the pattern seen in amyloid angiopathy. Previous autopsy studies have found vacuoles in the vessel wall, resulting in small aneurysms as a part of the Pompe syndrome.
CONCLUSIONS: There is an accumulating body of evidence that suggests cerebral vasculopathy as one of the primary manifestations of adult-onset Pompe's disease. This is manifested as dolichoectasia of basilar artery, aneurysms, and microhemorrhages that are central in distribution. The primary pathology is thought to be glycogen deposition in small- and medium-sized intracranial vessels. Controlling blood pressure aggressively and screening intracranial vascular imaging are recommended. Further definition of the syndrome is continuing from phenotypic and genotypic dimensions.

Entities:  

Year:  2014        PMID: 25566347      PMCID: PMC4280871     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  12 in total

1.  Neurological picture: Cerebral microbleeds in Pompe disease.

Authors:  Dimitri Renard; Pierre Labauge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-14       Impact factor: 10.154

2.  Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship?

Authors:  Johannes Brettschneider; Anne-D Sperfeld; Albert C Ludolph; Jan Kassubek
Journal:  Muscle Nerve       Date:  2008-09       Impact factor: 3.217

3.  Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease.

Authors:  F Martiniuk; A Chen; A Mack; E Arvanitopoulos; Y Chen; W N Rom; W J Codd; B Hanna; P Alcabes; N Raben; P Plotz
Journal:  Am J Med Genet       Date:  1998-08-27

4.  Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency.

Authors:  H A Kretzschmar; H Wagner; G Hübner; A Danek; T N Witt; P Mehraein
Journal:  J Neurol Sci       Date:  1990-09       Impact factor: 3.181

5.  Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease.

Authors:  Sabrina Sacconi; Jonathan D Bocquet; Stéphane Chanalet; Véronique Tanant; Leonardo Salviati; Claude Desnuelle
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

6.  Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling.

Authors:  M G Ausems; J Verbiest; M P Hermans; M A Kroos; F A Beemer; J H Wokke; L A Sandkuijl; A J Reuser; A T van der Ploeg
Journal:  Eur J Hum Genet       Date:  1999-09       Impact factor: 4.246

7.  Toward deconstructing the phenotype of late-onset Pompe disease.

Authors:  Angela Schüller; Stephan Wenninger; Nicola Strigl-Pill; Benedikt Schoser
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-01-17       Impact factor: 3.908

8.  Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease.

Authors:  Daniel Refai; Raisa Lev; Dewitt T Cross; Joshua S Shimony; Jeffery R Leonard
Journal:  Surg Neurol       Date:  2008-01-22

9.  alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).

Authors:  H G HERS
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

10.  Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe's disease).

Authors:  W E Braunsdorf
Journal:  Neurosurgery       Date:  1987-11       Impact factor: 4.654

View more
  5 in total

1.  Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).

Authors:  Matteo Garibaldi; Sabrina Sacconi; Giovanni Antonini; Claude Desnuelle
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

2.  Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.

Authors:  A Pichiecchio; S Sacco; P De Filippi; E Caverzasi; S Ravaglia; S Bastianello; C Danesino
Journal:  J Neurol       Date:  2017-08-30       Impact factor: 4.849

3.  Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

Authors:  Manuela Corti; Cristina Liberati; Barbara K Smith; Lee Ann Lawson; Ibrahim S Tuna; Thomas J Conlon; Kirsten E Coleman; Saleem Islam; Roland W Herzog; David D Fuller; Shelley W Collins; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2017-12       Impact factor: 5.032

4.  Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.

Authors:  Ole Hensel; Ilka Schneider; Mathias Wieprecht; Torsten Kraya; Stephan Zierz
Journal:  Orphanet J Rare Dis       Date:  2018-04-13       Impact factor: 4.123

5.  Glycogen accumulation in smooth muscle of a Pompe disease mouse model.

Authors:  Angela L McCall; Justin S Dhindsa; Aidan M Bailey; Logan A Pucci; Laura M Strickland; Mai K ElMallah
Journal:  J Smooth Muscle Res       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.